2014
DOI: 10.1186/1746-1596-9-67
|View full text |Cite
|
Sign up to set email alerts
|

High expression of DEK predicts poor prognosis of gastric adenocarcinoma

Abstract: BackgroundDEK, as an oncoprotein, plays an important role in cancer development and progression. This study aimed to investigate the clinicopathological significance of DEK overexpression in patients with gastric cancer.Materials and methodsThe expression of DEK protein was evaluated by immunohistochemical (IHC) staining of 172 gastric cancer samples with complete clinicopathological features, and the correlation between DEK expression and clinicopathological features was examined. Survival rates were also cal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
32
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(33 citation statements)
references
References 27 publications
(35 reference statements)
1
32
0
Order By: Relevance
“…DEK mRNA expression has been reported in mouse (http://www.brain-map.org/) and human brains (Kroes et al 2000), but to our knowledge, no studies have investigated protein expression nor neuroanatomical distribution in distinct brain regions. In the human adult brain, DEK mRNA expression is more heavily expressed in malignant brain tumors relative to normal controls (Kroes et al 2000), consistent with the reported increase of DEK expression in various cancers including breast (Privette Vinnedge et al 2015), bladder (Datta et al 2011) and gastric (Piao et al 2014). DEK mRNA is also expressed throughout the brain in adolescent (PND56) male mice, which is consistent with our observations in adult mice.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…DEK mRNA expression has been reported in mouse (http://www.brain-map.org/) and human brains (Kroes et al 2000), but to our knowledge, no studies have investigated protein expression nor neuroanatomical distribution in distinct brain regions. In the human adult brain, DEK mRNA expression is more heavily expressed in malignant brain tumors relative to normal controls (Kroes et al 2000), consistent with the reported increase of DEK expression in various cancers including breast (Privette Vinnedge et al 2015), bladder (Datta et al 2011) and gastric (Piao et al 2014). DEK mRNA is also expressed throughout the brain in adolescent (PND56) male mice, which is consistent with our observations in adult mice.…”
Section: Discussionsupporting
confidence: 81%
“…Aberrant expression or localization of the DEK DNA-binding protein has been associated with several diseases, including acute myeloid leukemia (Logan et al 2015, Von Lindern et al 1992), various types of solid tumors (Piao et al 2014, Privette Vinnedge et al 2015, Wang et al 2014), and as an auto-antigen in numerous auto-immune diseases, most notably juvenile idiopathic arthritis (Mor-Vaknin et al 2011, Sierakowska et al 1993, Szer et al 1994). DEK (human 6p22.3) is a unique protein, with no known homologs, that preferentially binds supercoiled and cruciform DNA in vitro .…”
Section: Introductionmentioning
confidence: 99%
“…11,12,16,17 Accordingly, DEK overexpression is significantly correlated with tumor growth, late pathological stage, and poor prognosis. [18][19][20][21] Although DEK has been studied in many tumor types, its expression and functions in astrocytic tumors are less known. In this study, we measured DEK expression in both normal brain tissues and astrocytic tumors.…”
Section: Introductionmentioning
confidence: 99%
“…DEK can promote the repair of DNA damage while also participates in apoptosis [6]. DEK has been already identified as an oncogene and is overexpressed in various malignant tumors, such as colorectal, gastric, neuroendocrine, prostate, breast, and bladder cancer [7][8][9][10][11]. Recent studies indicate that DEK depletion induced astrocytic tumor cell apoptosis with down-regulated expression of Bcl-2 and C-myc; the caspase-3 activity in the astrocytic tumor was also significantly enhanced after the knockdown [12].…”
Section: Introductionmentioning
confidence: 99%